Vector

Gene Technology is one of the open access journals in modern Biotechnology. The open access policy of the journals aims at increasing the visibility and accessibility of the published content and thus providing the desirable researches to the readers. It mainly provides expression of genes, taking advantage of natural genetic variation, modifying genes and transferring genes to new hosts, Environmental Biotechnology, Cell biology, Genetic Engineering and Molecular Biology, Tissue Engineering, Biosensor, Cancer Biology, Bioinformatics and Computational biology. Microparticles are small (<1.5 μm), anuclear cell vesicles that are released by several cell types during cell activation and apoptosis and that can be associated by their surface receptors to their cells of origin (e.g. platelets, endothelial cells, leukocytes) using flow cytometry. Microparticles can not only be used as surrogate markers but also act as inflammatory biological vectors in circulation. It has been found that microparticles bind to and fuse with distinct target cells suggesting that that they thereby deliver cytoplasm and presumably also specific surface receptors to their destination cells. “Philipp Diehl, Microparticles: Surrogate Markers & Biological Vectors in Cardiovascular Diseases” OMICS Group is among best open access publishers with expert reviewers and renowned scientists in its Editorial Board. Both editors and reviewers actively participate in the peer-review process and help in completing the review process within 21 days. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024